证券代码：301469 证券简称：恒达新材 公告编号：2025-017 浙江恒达新材料股份有限公司 关于回购公司股份方案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1、拟回购股份的方式：集中竞价交易方式； 2、拟回购股份的种类：公司已公开发行的人民币普通股（A 股）； 3、拟回购股份的用途：在未来适宜时机用于员工持股计划或股权激励；若 公司未能在本次股份回购实施结果暨股份变动公告日后的 3 年内使用完毕，则 将依法履行减少注册资本的程序，未使用股份将被注销（如国家对相关政策作 调整的则按调整后的政策执行）。 4、拟回购股份的价格区间：不超过人民币 36.34 元/股（含本数），该股份 回购价格上限不高于公司董事会通过回购股份决议前三十个交易日公司股票交 易均价的 150%，实际回购价格将综合回购实施期间公司二级市场股票价格、财 务状况和经营情况确定。 5、拟用于回购的资金总额：不低于人民币 1,500 万元（含本数）且不超过 人民币 3,000万元（含本数），具体以回购期限届满或回购实施完毕时实际使用 的资金总额为准。 6、拟回购股 ...

Financial Performance - The company's operating revenue for 2024 was CNY 1,007,627,562.37, representing a 15.99% increase compared to CNY 868,737,044.58 in 2023[21] - The net profit attributable to shareholders for 2024 was CNY 68,460,185.24, a decrease of 21.88% from CNY 87,634,496.44 in 2023[21] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 60,158,817.61, down 22.37% from CNY 77,497,205.41 in 2023[21] - The net cash flow from operating activities improved significantly to CNY 211,291,691.78, compared to a negative cash flow of CNY -197,120,607.74 in 2023, marking a 207.19% increase[21] - Basic and diluted earnings per share for 2024 were CNY 0.77, a decline of 34.75% from CNY 1.18 in 2023[21] - The total assets at the end of 2024 were CNY 1,684,780,586.10, a slight decrease of 0.80% from CNY 1,698,395,058.36 at the end of 2023[21] - The net assets attributable to shareholders at the end of 2024 were CNY 1,364,084,626.05, a minor decrease of 0.10% from CNY 1,365,433,419.18 in 2023[21] - The weighted average return on equity for 2024 was 5.02%, down from 10.28% in 2023, indicating a decline of 5.26%[21] Revenue Breakdown - Total revenue for the year was 1,007,627,562.37 CNY, with a quarterly breakdown of 253.55 million CNY in Q1, 254.25 million CNY in Q2, 239.72 million CNY in Q3, and 260.11 million CNY in Q4[23] - Net profit attributable to shareholders was 68,459,185.24 CNY for the year, with quarterly figures of 16.69 million CNY in Q1, 22.52 million CNY in Q2, 13.93 million CNY in Q3, and 15.32 million CNY in Q4[23] - Cash generated from operating activities totaled 211,291,691.78 CNY for the year, with Q1 at 66.54 million CNY, Q2 at 89.69 million CNY, Q3 at 11.89 million CNY, and Q4 at 43.18 million CNY[24] Market and Industry Insights - The company reported a 5.00% year-on-year GDP growth in China for 2024, with the paper and paper products industry revenue increasing by 3.90% to 1,456.62 billion CNY[31] - The production of mechanical paper and cardboard in China reached 15,846.90 million tons in 2024, marking an 8.60% increase year-on-year[31] - The company focuses on the R&D, production, and sales of specialty paper, with a strategic shift towards medical and food packaging paper products[33] - The company has established a leading position in the high-end medical and food packaging paper market, enhancing its brand recognition[33] Research and Development - The company has 43 patents, including 38 invention patents, showcasing its commitment to research and development[45] - The company’s research and development expenses increased by 9.44% to CNY 38,792,857.81[61] - The company completed several key R&D projects, including self-heating antibacterial food packaging and high-absorption decorative base paper, aimed at enhancing product quality and competitiveness[62] Operational Strategies - The company adopts a "make-to-order" production model, aligning production with customer demand to enhance efficiency[40] - The company has a stable and efficient management team with extensive industry knowledge, enabling effective responses to market changes[48] - The company has implemented a comprehensive quality control system, ensuring product quality stability and timely response to customer needs[47] Financial Management - The company has not reported any significant discrepancies between financial data under international and Chinese accounting standards[25] - The company’s procurement strategy is based on market demand and pricing trends, allowing for flexible inventory management[39] - The company’s cash and cash equivalents decreased by ¥220,296,480.22 in 2024, marking a decline of 172.16% compared to an increase of ¥305,280,158.43 in 2023[63] Dividend and Profit Distribution - The company plans to distribute a cash dividend of CNY 3.5 per 10 shares, totaling CNY 30,000,000 based on 88,421,400 shares[4] - The total distributable profit available to shareholders is RMB 200,326,845.19, with the cash dividend representing 100% of the profit distribution[153] - The cash dividend distribution plan is subject to approval at the upcoming annual general meeting[154] Governance and Compliance - The company has established a transparent information disclosure system, ensuring equal access to information for all shareholders[109] - The company has a governance structure with a board of directors and senior management team, including a chairman and a general manager[121] - The company has not faced any regulatory penalties for its directors or senior management in the past three years[135] Environmental Responsibility - The company invested approximately 21.41 million yuan in environmental protection efforts during 2024[165] - The company has implemented a comprehensive environmental protection management system, ensuring no administrative penalties for environmental issues[162] - The company has actively engaged in low-carbon production actions, optimizing production processes and upgrading equipment to reduce carbon emissions[166] Future Outlook and Expansion Plans - The company plans to enhance its product line and brand influence by focusing on the trend of replacing plastic with paper and increasing the added value of its products through downstream processing[94] - The company is exploring potential mergers and acquisitions to strengthen its market position[84] - The company aims to become the largest domestic producer of high-end medical and food packaging paper in the short to medium term, and expand into other consumer goods packaging paper in the long term[92][93]

Financial Performance - The company's operating revenue for Q1 2025 was ¥242,489,604.89, a decrease of 4.36% compared to ¥253,550,166.11 in the same period last year[5] - Net profit attributable to shareholders was ¥13,232,229.74, down 20.70% from ¥16,685,260.91 year-on-year[5] - Basic and diluted earnings per share decreased by 21.05% to ¥0.15 from ¥0.19 in the same period last year[5] - The operating profit for the current period is 14,515,230.46, down from 18,162,376.15, reflecting a decline of 20.06%[22] - The total comprehensive income for the current period is 13,232,229.74, compared to 16,685,260.91 in the previous period, indicating a decrease of 20.69%[22] Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥40,269,735.75, representing a decline of 160.52% compared to ¥66,537,056.12 in the previous year[5] - Cash and cash equivalents decreased to CNY 176,413,956.67 from CNY 260,617,662.13, indicating a liquidity contraction[18] - Cash inflow from investment activities is 183,339,057.47, while cash outflow is 202,221,098.15, resulting in a net cash flow of -18,882,040.68[25] - The cash and cash equivalents at the end of the period are 421,552,423.42, down from 507,044,712.58 at the beginning of the period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,659,180,247.99, down 1.52% from ¥1,684,780,586.10 at the end of the previous year[5] - Current liabilities decreased to CNY 194,332,051.40 from CNY 198,297,658.10, indicating improved liability management[19] - Non-current liabilities decreased significantly to CNY 92,630,759.32 from CNY 122,398,301.95, reflecting a reduction in long-term debt[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,074[11] - The top shareholder, Pan Chang, holds 37.86% of the shares, totaling 33,873,000 shares[11] - The company has a significant shareholder, Pan Chang, holding 33,873,000 restricted shares, which will be released on February 22, 2027[14] - The company has a total of 12,650,821 unrestricted shares held by Qizhou Guanghui Investment Management Partnership[12] - The company has a total of 8,110,000 unrestricted shares held by Longyou Lianlong Equity Investment Fund Partnership[12] - The company has a total of 2,266,046 unrestricted shares held by Jiang Wenlong[12] Share Repurchase - The company plans to repurchase shares with a total amount not less than RMB 25 million and not exceeding RMB 50 million, with a maximum repurchase price of RMB 39.37 per share[15] - As of March 11, 2025, the company has repurchased 1,058,600 shares, accounting for 1.1831% of the total share capital, with a total transaction amount of RMB 25,097,637[16] - The maximum transaction price for repurchased shares was RMB 28.85 per share, while the minimum was RMB 20.28 per share[16] - The company has adjusted the maximum repurchase price to RMB 38.81 per share starting from June 25, 2024, due to the implementation of the 2023 annual equity distribution[15] Operational Costs and Expenses - Total operating costs for the current period are CNY 231,971,793.80, down from CNY 237,975,470.73, reflecting a cost reduction strategy[21] - The company reported an increase in R&D expenses to CNY 8,909,652.17 from CNY 8,607,209.36, emphasizing commitment to innovation[21] - The company paid 24,415,651.67 in cash to employees, an increase from 21,958,463.26 in the previous period[25] Government Support - The company received government subsidies amounting to ¥857,755.09 during the reporting period[6] - The company received 7,495,442.55 in tax refunds related to operating activities during the current period[25] Miscellaneous - The company has not disclosed any significant changes in the shareholding structure of the top 10 shareholders due to the transfer of shares[12] - The company has a total of 55,242,979 restricted shares at the beginning of the period, with 17,808,800 shares released and 5,987,136 shares added, resulting in 43,421,315 restricted shares at the end of the period[14] - The company has not undergone an audit for the first quarter report[27]

证券代码：301469 证券简称：恒达新材 公告编号：2025-007 浙江恒达新材料股份有限公司 关于股份回购结果暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 浙江恒达新材料股份有限公司（以下简称"公司"）于 2024 年 3 月 12 日召开 第三届董事会第十六次会议审议通过了《关于回购公司股份方案的议案》，同意 公司以自有资金通过集中竞价交易方式回购公司部分股份，并在未来适宜时机 将回购股份用于员工持股计划或股权激励。回购股份的种类为公司发行的人民 币普通股（A 股）股票；本次回购股份的资金总额不低于人民币 2,500 万元且不 超过人民币 5,000 万元，回购价格为不超过人民币 39.37 元/股。回购期限为自董 事会审议通过回购股份方案之日起 12个月内。具体内容详见公司于 2024年 3月 12日披露于巨潮资讯网（http://www.cninfo.com.cn）的《关于回购公司股份方案 的公告》（公告编号：2024-004）。 因公司实施 2023 年度权益分派，回购价格上限自 2024 年 6 月 25 日起由 39.37 ...

证券代码：301469 证券简称：恒达新材 公告编号：2025-006 浙江恒达新材料股份有限公司 关于持股 5%以上股东减持计划期满暨实施结果的公告 公司股东龙游联龙股权投资基金合伙企业（有限合伙）保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 1、龙游联龙本次减持计划符合《中华人民共和国公司法》《中华人民共和 1、股东减持股份情况 公司股东龙游联龙在上述减持计划期间内未减持公司股票。 | 股东名称 | 股份性质 | | 本次减持前持有股份 | | 本次减持后持有股份 | | --- | --- | --- | --- | --- | --- | | | | 股数（万 | 占总股本比 | 股数（万 | 占总股本 | | | | 股） | 例（%） | 股） | 比例（%） | | 龙游联龙 | 合计持有股份 | 811 | 9.13 | 811 | 9.17 | | | 其中：无限售条件股份 | 811 | 9.13 | 811 | 9.17 | | | 有限售条件股份 | ...

证券代码：301469 证券简称：恒达新材 公告编号：2025-005 浙江恒达新材料股份有限公司 关于回购公司股份的进展公告 因公司实施 2023 年度权益分派，回购价格上限自 2024 年 6 月 25 日起由 39.37 元/股调整为 38.81 元/股。具体内容详见公司于 2024 年 6 月 18 日披露于巨 潮资讯网（http://www.cninfo.com.cn）的《关于 2023 年年度权益分派实施后调 整回购价格上限的公告》（公告编号：2024-034）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9号——回购股份》等相关规定，上市公司应当在回购期间每个月的前三个交易 日内，披露截至上月末的回购进展情况。现将公司回购股份的进展情况公告如 下： 一、回购公司股份的进展情况 证券代码：301469 证券简称：恒达新材 公告编号：2025-005 截至 2025年 2月 28日，公司通过回购专用证券账户以集中竞价交易方式回 购公司股份 1,058,600 股，占公司当前总股本的 1.1831%，购买股份的最高成交 价为 28.85元/股，最低成交价为 20.28元/股， ...

证券代码：301469 证券简称：恒达新材 公告编号：2025-004 浙江恒达新材料股份有限公司 关于部分首次公开发行前已发行股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 截至本公告披露日，公司总股本为 89,480,000 股，其中无限售条件的股票 数量为 34,237,021 股，占发行后总股本的比例为 38.2622%；有限售条件的股票 数量为 55,242,979 股，占发行后总股本的比例为 61.7378%。 特别提示： 1、本次解除限售的股份为浙江恒达新材料股份有限公司（以下简称"公司" 或"恒达新材"）首次公开发行前已发行的部分股份； 2、本次申请解除限售股东户数共计 2 户，解除限售股份的数量为 17,808,800 股，占公司总股本的 19.9025%，限售期为自公司首次公开发行股票 并上市之日起 18 个月； 3、本次解除限售的股份上市流通日期为 2025 年 2 月 24 日（星期一）。 一、 首次公开发行前已发行股份概况 根据中国证券监督管理委员会出具的《关于同意浙江恒达新材料股份有限 公司首次公开发行股票 ...

中信建投证券股份有限公司 关于浙江恒达新材料股份有限公司 部分首次公开发行前已发行股份上市流通的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐人"）作 为浙江恒达新材料股份有限公司（以下简称"恒达新材"、"上市公司"或"公 司"）首次公开发行股票并在创业板上市的保荐人，根据《证券发行上市保荐业 务管理办法》《深圳证券交易所创业板股票上市规则》及《深圳证券交易所上市 公司自律监管指引第 2 号—创业板上市公司规范运作》等有关规定，对恒达新材 部分首次公开发行前已发行股份上市流通的事项进行了核查，核查情况及核查意 见如下： 一、首次公开发行前已发行股份概况 根据中国证券监督管理委员会出具的《关于同意浙江恒达新材料股份有限公 司首次公开发行股票注册的批复》（证监许可〔2023〕1341 号），公司首次公 开发行人民币普通股（A 股）股票 22,370,000 股，每股发行价格为 36.58 元，并 于 2023 年 8 月 22 日在深圳证券交易所创业板上市交易。 公司首次公开发行前总股本 67,110,000 股，首次公开发行股票完成后，公司 总股本为 89,480,000 股，其中无限售条 ...

证券代码：301469 证券简称：恒达新材 公告编号：2025-003 浙江恒达新材料股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 浙江恒达新材料股份有限公司（以下简称"公司"）于 2024 年 3 月 12 日召开 第三届董事会第十六次会议审议通过了《关于回购公司股份方案的议案》，同意 公司以自有资金通过集中竞价交易方式回购公司部分股份，并在未来适宜时机 将回购股份用于员工持股计划或股权激励。回购股份的种类为公司发行的人民 币普通股（A 股）股票；本次回购股份的资金总额不低于人民币 2,500 万元且不 超过人民币 5,000 万元，回购价格为不超过人民币 39.37 元/股。回购期限为自董 事会审议通过回购股份方案之日起 12个月内。具体内容详见公司于 2024年 3月 12日披露于巨潮资讯网（http://www.cninfo.com.cn）的《关于回购公司股份方案 的公告》（公告编号：2024-004）。 因公司实施 2023 年度权益分派，回购价格上限自 2024 年 6 月 25 日起由 39.37 元/ ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 浙江恒达新材料股份有限公司（以下简称"公司"）于 2024 年 3 月 12 日召开 第三届董事会第十六次会议审议通过了《关于回购公司股份方案的议案》，同意 公司以自有资金通过集中竞价交易方式回购公司部分股份，并在未来适宜时机 将回购股份用于员工持股计划或股权激励。回购股份的种类为公司发行的人民 币普通股（A 股）股票；本次回购股份的资金总额不低于人民币 2,500 万元且不 超过人民币 5,000 万元，回购价格为不超过人民币 39.37 元/股。回购期限为自董 事会审议通过回购股份方案之日起 12个月内。具体内容详见公司于 2024年 3月 12日披露于巨潮资讯网（http://www.cninfo.com.cn）的《关于回购公司股份方案 的公告》（公告编号：2024-004）。 证券代码：301469 证券简称：恒达新材 公告编号：2025-002 浙江恒达新材料股份有限公司 关于回购公司股份比例达到 1%的进展公告 1、公司未在下列期间内回购公司股份： 因公司实施 2023 年度权益分派，回购价格上限自 ...